GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RaySearch Laboratories AB (publ) RAY B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

172.20

-2.55%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 1.34bn

FY2016FY2025

Net income

SEK 227.8m

FY2016FY2025

Free cash flow

SEK 358.9m

FY2016FY2025

Shareholders' equity

SEK 985.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 1.34bnSEK 1.19bnSEK 1.02bnSEK 843.6mSEK 641.7mSEK 651.6mSEK 741.6mSEK 627.2mSEK 585.1mSEK 531.5m
Research and developmentSEK 50.7mSEK 269.4mSEK 237.7mSEK 238.8mSEK 233.4mSEK 185.0mSEK 174.7mSEK 147.7mSEK 104.3mSEK 93.2m
Operating incomeSEK 321.8mSEK 260.5mSEK 114.9mSEK 42.7m−SEK 53.3m−SEK 3.5mSEK 68.2mSEK 94.7mSEK 159.7mSEK 199.6m
Net incomeSEK 227.8mSEK 203.5mSEK 81.6mSEK 23.8m−SEK 47.3m−SEK 9.1mSEK 50.4mSEK 78.5mSEK 117.6mSEK 151.4m
Diluted earnings per share6.645.942.380.69-1.38-0.261.472.293.434.40

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 1.99bnSEK 2.09bnSEK 1.95bnSEK 1.88bnSEK 1.74bnSEK 1.28bnSEK 1.26bnSEK 1.11bnSEK 915.1mSEK 717.3m
Cash and short-term investmentsSEK 407.3mSEK 462.7mSEK 343.7mSEK 160.3mSEK 102.5mSEK 168.7mSEK 113.9mSEK 112.2mSEK 104.2mSEK 87.7m
Total liabilitiesSEK 1.01bnSEK 1.21bnSEK 1.22bnSEK 1.22bnSEK 1.09bnSEK 590.6mSEK 558.8mSEK 448.0mSEK 334.6mSEK 257.1m
DebtSEK 394.8mSEK 471.9mSEK 529.4mSEK 556.1mSEK 562.3mSEK 146.3mSEK 170.7mSEK 131.5mSEK 83.8mSEK 61.5m
Shareholders' equitySEK 985.3mSEK 876.7mSEK 735.2mSEK 657.2mSEK 649.3mSEK 694.4mSEK 705.5mSEK 657.5mSEK 580.4mSEK 460.2m
Shares outstanding34m34m34m34m34m34m34m34m34m34m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 387.0mSEK 485.2mSEK 455.9mSEK 356.8mSEK 238.2mSEK 331.5mSEK 320.1mSEK 178.5mSEK 147.5mSEK 120.8m
Capital spending−SEK 28.1m−SEK 217.5m−SEK 209.3m−SEK 231.5m−SEK 255.2m−SEK 225.6m−SEK 212.0m−SEK 223.6m−SEK 148.8m−SEK 106.9m
Free cash flowSEK 358.9mSEK 267.7mSEK 246.6mSEK 125.3m−SEK 17.1mSEK 105.9mSEK 108.1m−SEK 45.2m−SEK 1.3mSEK 13.9m
Dividends paid−SEK 102.8m−SEK 68.6m———————−SEK 8.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 272.3mSEK 290.3mSEK 375.4mSEK 332.3mSEK 304.9mSEK 331.7mSEK 322.7mSEK 293.3m
Operating incomeSEK 24.5mSEK 53.9mSEK 101.7mSEK 89.2mSEK 36.4mSEK 74.8mSEK 73.6mSEK 61.8m
Net incomeSEK 19.6mSEK 53.2mSEK 68.6mSEK 71.6mSEK 30.8mSEK 56.8mSEK 60.0mSEK 45.4m
Diluted earnings per share0.571.552.002.090.901.661.751.32
Cash from operationsSEK 133.0mSEK 116.0mSEK 173.0m−SEK 11.0mSEK 70.0mSEK 146.0mSEK 102.0mSEK 60.0m
Capital spending−SEK 6.0m−SEK 6.0m−SEK 6.0m−SEK 51.0m−SEK 52.0m−SEK 61.0m−SEK 60.0m−SEK 38.0m
Free cash flowSEK 127.0mSEK 110.0mSEK 167.0m−SEK 62.0mSEK 18.0mSEK 85.0mSEK 42.0mSEK 22.0m
Total assetsSEK 1.82bnSEK 2.03bnSEK 1.99bnSEK 1.94bnSEK 1.99bnSEK 2.06bnSEK 2.09bnSEK 2.02bn
Cash and short-term investmentsSEK 213.1mSEK 439.3mSEK 407.3mSEK 322.8mSEK 402.8mSEK 503.4mSEK 462.7mSEK 425.0m
DebtSEK 78.9mSEK 78.5mSEK 394.8mSEK 411.1mSEK 430.0mSEK 449.4mSEK 549.0mSEK 477.4m
Shareholders' equitySEK 788.4mSEK 1.04bnSEK 985.3mSEK 919.3mSEK 848.9mSEK 922.0mSEK 876.7mSEK 810.7m

Financial ratios

Data as of 12 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin23.9%22.8%11.7%5.2%-8.2%-0.1%
Net margin16.9%17.1%8.0%2.8%-7.4%-1.4%
Return on equity23.1%23.2%11.1%3.6%-7.3%-1.3%
Return on assets11.4%9.7%4.2%1.3%-2.7%-0.7%
Free cash flow yield6.2%10.6%10.0%8.8%7.4%8.4%
Revenue growth12.8%16.6%21.2%31.5%-1.5%-12.1%
Earnings growth11.9%149.5%243.1%-150.3%421.1%-118.0%
Current ratio1.70x1.40x1.19x1.02x1.05x1.35x
Debt to equity0.08x0.09x0.13x0.85x0.87x0.21x
Equity ratio49.5%41.9%37.7%35.0%37.3%54.0%
Interest coverage41.26x30.05x12.37x3.82x-8.72x-0.13x
R&D as a share of sales3.8%22.6%23.3%28.3%36.4%28.4%
Buybacks as a share of market value-0.0%-0.0%0.0%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.8%15.6%13.0%
Operating income96.0%—12.9%
Net income112.4%—12.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin23.0%16.8%12.0%15.2%
Net margin17.0%12.2%8.4%11.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings34.336.438.098.0-40.9-312.372.942.149.841.9
Price to sales5.86.23.02.83.04.35.05.310.011.9

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 8 May 2026.

FY2026FY2025FY2024FY2016FY2011FY2010FY2008
Paid in the year4.003.001.300.250.500.500.167
  • 3-for-1 split · 25 Jun 2008
  • 20-to-1 reverse split · 10 Jun 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.